Milliman Funds ETF (MHIG) Holdings
MHIG holdings summary
as of Oct 25, 2026- Holdings
- 79 positions listed
- Top 10 weight
- 62.9% of net assets
- Effective holdings
- 7 equal-weight equivalent
- Largest holding
- XHLF 20.01% Bondbloxx ETF Trust - BondBloxx…
- Annual turnover
- — of the portfolio traded
All MHIG holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | XHLF | Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | Other | 20.01% | $203,228.63 | — | — |
| 2 | XFIV | Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | Other | 19.68% | $199,947.55 | — | — |
| 3 | LLY | Eli Lilly and Company | Healthcare | 6.62% | $67,228.54 | $1.12T | 42.2 |
| 4 | SPY | SPDR S&P 500 ETF Trust | Other | 6.17% | $62,633.00 | — | — |
| 5 | JNJ | Johnson & Johnson | Healthcare | 2.81% | $28,556.54 | $615.87B | 38.8 |
| 6 | ABBV | AbbVie Inc. | Healthcare | 2.52% | $25,638.10 | $504.37B | 80.6 |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 1.58% | $16,099.62 | $255.13B | 37.1 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 1.33% | $13,536.72 | $193.67B | — |
| 9 | AMGN | Amgen Inc. | Healthcare | 1.15% | $11,685.91 | $233.82B | 26.9 |
| 10 | DHR | Danaher Corporation | Healthcare | 1.05% | $10,653.85 | $161.01B | 40.8 |
| 11 | UNH | UnitedHealth Group Incorporated | Healthcare | 0.89% | $8,990.96 | $360.32B | 25.8 |
| 12 | ISRG | Intuitive Surgical, Inc. | Healthcare | 0.87% | $8,798.97 | $150.74B | 48.9 |
| 13 | ABT | Abbott Laboratories | Healthcare | 0.85% | $8,678.09 | $181.50B | 33.8 |
| 14 | PFE | Pfizer Inc. | Healthcare | 0.77% | $7,860.36 | $168.60B | 38.9 |
| 15 | MDT | Medtronic plc | Healthcare | 0.71% | $7,251.89 | $121.20B | 23.3 |
| 16 | SYK | Stryker Corporation | Healthcare | 0.64% | $6,545.90 | $113.02B | 30.5 |
| 17 | CVS | CVS Health Corporation | Healthcare | 0.63% | $6,408.76 | $118.13B | 24.3 |
| 18 | BMY | Bristol-Myers Squibb Company | Healthcare | 0.61% | $6,189.35 | $122.05B | 13.2 |
| 19 | HCA | HCA Healthcare, Inc. | Healthcare | 0.53% | $5,378.73 | $99.34B | 15.4 |
| 20 | NTRA | Natera, Inc. | Healthcare | 0.49% | $4,953.10 | $56.71B | — |
| 21 | MCK | McKesson Corporation | Healthcare | 0.48% | $4,861.68 | $117.15B | 26.9 |
| 22 | ELV | Elevance Health Inc. | Healthcare | 0.46% | $4,652.42 | $92.88B | 19.0 |
| 23 | BSX | Boston Scientific Corporation | Healthcare | 0.40% | $4,050.05 | $64.33B | 18.0 |
| 24 | MRK | Merck & Co., Inc. | Healthcare | 0.39% | $3,957.61 | $360.08B | 115.8 |
| 25 | CI | Cigna Corporation | Healthcare | 0.39% | $3,923.07 | $79.88B | 12.5 |
| 26 | CNC | Centene Corporation | Healthcare | 0.36% | $3,617.31 | $34.16B | — |
| 27 | VEEV | Veeva Systems Inc. | Healthcare | 0.34% | $3,436.50 | $50.25B | 50.9 |
| 28 | HUM | Humana Inc. | Healthcare | 0.33% | $3,337.96 | $49.61B | 39.1 |
| 29 | BDX | Becton, Dickinson and Company | Healthcare | 0.31% | $3,122.61 | $52.23B | 44.6 |
| 30 | WAT | Waters Corporation | Healthcare | 0.30% | $3,095.18 | $42.90B | 110.6 |
| 31 | RMD | ResMed Inc. | Healthcare | 0.29% | $2,950.94 | $33.61B | 22.9 |
| 32 | MDLN | Medline Inc. | Healthcare | 0.29% | $2,949.92 | $48.38B | 89.9 |
| 33 | IQV | IQVIA Holdings Inc. | Healthcare | 0.29% | $2,943.83 | $43.93B | 33.2 |
| 34 | EW | Edwards Lifesciences Corporation | Healthcare | 0.27% | $2,719.33 | $49.92B | 51.5 |
| 35 | A | Agilent Technologies, Inc. | Healthcare | 0.27% | $2,703.08 | $48.77B | 34.1 |
| 36 | DXCM | DexCom, Inc. | Healthcare | 0.25% | $2,493.82 | $32.47B | 34.1 |
| 37 | COR | Cencora | Healthcare | 0.23% | $2,370.91 | $65.06B | 25.3 |
| 38 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.23% | $2,292.69 | $25.94B | 24.6 |
| 39 | ILMN | Illumina, Inc. | Healthcare | 0.22% | $2,256.12 | $39.64B | 49.0 |
| 40 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.19% | $1,974.74 | $25.79B | 26.3 |
| 41 | GH | Guardant Health, Inc. | Healthcare | 0.18% | $1,824.40 | $21.28B | — |
| 42 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.16% | $1,651.71 | $32.51B | 36.6 |
| 43 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.15% | $1,497.31 | $38.14B | — |
| 44 | STE | STERIS plc | Healthcare | 0.14% | $1,425.19 | $21.71B | 27.2 |
| 45 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.13% | $1,326.65 | $17.26B | 36.3 |
| 46 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.13% | $1,315.48 | $31.02B | 39.1 |
| 47 | THC | Tenet Healthcare Corporation | Healthcare | 0.11% | $1,130.60 | $21.52B | 10.5 |
| 48 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.11% | $1,124.50 | $27.03B | 49.4 |
| 49 | RVTY | Revvity, Inc. | Healthcare | 0.11% | $1,112.32 | $17.03B | 73.0 |
| 50 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.11% | $1,069.65 | $14.46B | — |
| 51 | COO | The Cooper Companies, Inc. | Healthcare | 0.10% | $1,031.05 | $11.02B | 19.9 |
| 52 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.10% | $1,003.62 | $18.12B | 23.1 |
| 53 | SOLV | Solventum Corporation | Healthcare | 0.10% | $1,003.62 | $14.61B | 10.5 |
| 54 | MRNA | Moderna, Inc. | Healthcare | 0.10% | $997.53 | $87.04B | — |
| 55 | ALGN | Align Technology, Inc. | Healthcare | 0.09% | $936.58 | $10.46B | 25.6 |
| 56 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.08% | $818.75 | $81.41B | 19.6 |
| 57 | AVTR | Avantor, Inc. | Healthcare | 0.08% | $800.46 | $11.11B | — |
| 58 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.08% | $788.27 | $31.42B | 16.0 |
| 59 | TEM | Tempus AI, Inc. | Healthcare | 0.08% | $768.97 | $11.68B | — |
| 60 | GMED | Globus Medical, Inc. | Healthcare | 0.08% | $767.95 | $10.30B | 19.7 |
| 61 | BIIB | Biogen Inc. | Healthcare | 0.08% | $764.91 | $34.37B | 41.3 |
| 62 | EHC | Encompass Health Corporation | Healthcare | 0.07% | $758.81 | $12.61B | 21.4 |
| 63 | TECH | Bio-Techne Corporation | Healthcare | 0.07% | $758.81 | $11.38B | 62.6 |
| 64 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.07% | $745.61 | $13.79B | 19.9 |
| 65 | PEN | Penumbra, Inc. | Healthcare | 0.06% | $631.84 | $12.64B | 78.8 |
| 66 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 0.05% | $555.65 | $126.66B | 28.9 |
| 67 | UHS | Universal Health Services, Inc. | Healthcare | 0.05% | $544.48 | $10.91B | 7.6 |
| 68 | DVA | DaVita Inc. | Healthcare | 0.05% | $538.38 | $11.95B | 15.8 |
| 69 | BTSG | BrightSpring Health Services, Inc. | Healthcare | 0.05% | $530.25 | $12.04B | 53.9 |
| 70 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.05% | $474.38 | $11.67B | — |
| 71 | EXEL | Exelixis, Inc. | Healthcare | 0.04% | $442.89 | $15.42B | 19.6 |
| 72 | BAX | Baxter International Inc. | Healthcare | 0.04% | $434.77 | $13.07B | — |
| 73 | ENSG | The Ensign Group, Inc. | Healthcare | 0.04% | $367.72 | $10.29B | 27.7 |
| 74 | NK | NantKwest Inc | Healthcare | 0.04% | $365.69 | — | — |
| 75 | INCY | Incyte Corporation | Healthcare | 0.04% | $363.66 | $22.92B | 14.4 |
| 76 | RPRX | Royalty Pharma plc | Healthcare | 0.03% | $257.00 | $35.22B | 32.4 |
| 77 | INSM | Insmed Incorporated | Healthcare | 0.02% | $184.88 | $21.02B | — |
| 78 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.01% | $58.92 | $10.58B | 147.8 |
| 79 | VTRS | Viatris Inc. | Healthcare | 0.01% | $56.89 | $21.43B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($1.0M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
MHIG sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Other | 45.9% | 3 | XHLF, XFIV, SPY |
| Healthcare | 33.4% | 76 | LLY, JNJ, ABBV |
Sum of the weights of the holdings in each sector.
MHIG top industries
MHIG overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| MHIP | Milliman Funds ETF | 39.7% | 78 of 83 | — |
| SPY | SPDR S&P 500 ETF | 8.9% | 55 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 8.4% | 75 of 2,941 | 0.03% |
| DIA | SPDR Dow Jones Industrial Average ETF | 5.2% | 4 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 3.2% | 9 of 101 | 0.17% |
| IWM | iShares Russell 2000 ETF | 0.1% | 1 of 1,962 | 0.19% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the MHIG portfolio
Milliman Funds ETF holds 79 positions. The ten largest make up 62.9% of the fund and the top 50 77.5%, so it behaves like a portfolio of about 7 equally weighted positions. The biggest positions are Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF (20.01%), Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (19.68%), Eli Lilly and Company (6.62%), SPDR S&P 500 ETF Trust (6.17%), Johnson & Johnson (2.81%).
Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: MHIG chart, MHIG bond profile, MHIG overview.
MHIG holdings FAQ
How many holdings does MHIG have?
MHIG holds 79 positions as of October 25, 2026.
What are the top 10 holdings of MHIG?
The ten largest holdings are Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF (20.01%), Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (19.68%), Eli Lilly and Company (6.62%), SPDR S&P 500 ETF Trust (6.17%), Johnson & Johnson (2.81%), AbbVie Inc. (2.52%), Thermo Fisher Scientific Inc. (1.58%), Gilead Sciences, Inc. (1.33%), Amgen Inc. (1.15%), Danaher Corporation (1.05%). Together they are 62.9% of the fund.
What percentage of MHIG is Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target…?
Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF is the largest holding at 20.01% of net assets, about $203,228.63 of the fund's $1.0M.
How concentrated is MHIG?
The top 10 holdings are 62.9% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) MHIG behaves like a portfolio of about 7 equally weighted positions.